Crossmark

Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma

Crossref DOI link: https://doi.org/10.1007/s10388-021-00873-7

Published Online: 2021-08-22

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kadota, Tomohiro https://orcid.org/0000-0002-0408-3494
Sato, Daiki

Inaba, Atsushi

Nishihara, Keiichiro

Takashima, Kenji

Nakajo, Keiichiro

Yukami, Hiroki

Mishima, Saori

Sawada, Kentaro

Kotani, Daisuke

Fujiwara, Hisashi

Nakamura, Masaki

Hojo, Hidehiro

Yoda, Yusuke

Kojima, Takashi

Fujita, Takeo

Yano, Tomonori
License Information

Text and Data Mining valid from 2021-08-22

Version of Record valid from 2021-08-22
More Information

Article History

Received: 6 March 2021

Accepted: 18 August 2021

First Online: 22 August 2021

Declarations

:

: Tomohiro Kadota, Daiki Sato, Atsushi Inaba, Keiichiro Nishihara, Kenji Takashima, Keiichiro Nakajo, Hiroki Yukami, Saori Mishima, Kentaro Sawada, Daisuke Kotani, Hisashi Fujiwara, Masaki Nakamura, Hidehiro Hojo, Yusuke Yoda, Takashi Kojima, Takeo Fujita, and Tomonori Yano declare that they have no conflict of interest.

: This study was a single center, retrospective study, and the protocol was approved by the Institutional Review Board of the National Cancer Center (2017-434), performed according to the Epidemiological Study Guideline issued by the Japan Ministry of Health, Labor, and Welfare and the ethical principles of the revised Declaration of Helsinki. All data were collected from medical records.

: All procedures were carried out after written informed consent was obtained from all patients.

Document is current

Any future updates will be listed below